Loading…
Reported covered position: 1999-2000 Legislative Staff Assistant, Sen. Mitch McConnell2005-06 Health Policy Analyst and Counsel for Sen. Jon Kyl,Chrmn. of Senate Republican Policy Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
General health care reform, appropriations for implementation of Second Chance Act of 2007 (HR 1593/S.1060), improvements to and appropriations for substance abuse and mental health treatment programs in Department of Veterns Affairs, inclusion of Alkermes products on VA Formulary, mental health parity specific to substance abuse treatment, revised billing codes for Vivitrol injection, creation of Vivitrol provider education program within CSAT at SAMHSA, patent reform
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALKERMES, INC. via ALKERMES, INC.
2010 · first_quarter · 1T
Appropriations for Second Chance Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via ALKERMES, INC.
2009 · fourth_quarter · Q4
Source: Senate LDA
General health care reform, appropriations for implementation of Second Chance Act of 2007 (HR 1593/S.1060), improvements to and appropriations for substance abuse and mental health treatment programs in Department of Veterns Affairs, inclusion of Alkermes products on VA Formulary, mental health parity specific to substance abuse treatment, revised billing codes for Vivitrol injection, creation of Vivitrol provider education program within CSAT at SAMHSA, patent reform
General health care reform, appropriations for implementation of Second Chance Act of 2007 (HR 1593/S.1060), improvements to and appropriations for substance abuse and mental health treatment programs in Department of Veterns Affairs, inclusion of Alkermes products on VA Formulary, mental health parity specific to substance abuse treatment, revised billing codes for Vivitrol injection, creation of Vivitrol provider education program within CSAT at SAMHSA, patent reform
General health care reform, appropriations for implementation of Second Chance Act of 2007 (HR 1593/S.1060), improvements to and appropriations for substance abuse and mental health treatment programs in Department of Veterns Affairs, inclusion of Alkermes products on VA Formulary, mental health parity specific to substance abuse treatment, revised billing codes for Vivitrol injection, creation of Vivitrol provider education program within CSAT at SAMHSA, patent reform
Utilization of Vivitrol in the Federal Bureau of Prisons as part of a treatment program for alcohol dependence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via ALKERMES, INC.
2009 · third_quarter · Q3
Utilization of Vivitrol in the Federal Bureau of Prisons as part of a treatment program for alcohol dependence.
Filing targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via ALKERMES, INC.
2009 · second_quarter · Q2
Utilization of Vivitrol in Federal Bureau of Prisons substance use disorders treatment program for alcohol dependence
Filing targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
ALKERMES, INC. via ALKERMES, INC.
2009 · third_quarter · RR
General health care reform, appropriations for implementation of Second Chance Act of 2007 (HR 1593/S.1060), improvements to and appropriations for substance abuse and mental health treatment programs in Department of Veterns Affairs, inclusion of Alkermes products on VA Formulary, mental health parity specific to substance abuse treatment, revised billing codes for Vivitrol injection, creation of Vivitrol provider education program within CSAT at SAMHSA, patent reform
General health care reform, appropriations for implementation of Second Chance Act of 2007 (HR 1593/S.1060), improvements to and appropriations for substance abuse and mental health treatment programs in Department of Veterns Affairs, inclusion of Alkermes products on VA Formulary, mental health parity specific to substance abuse treatment, revised billing codes for Vivitrol injection, creation of Vivitrol provider education program within CSAT at SAMHSA, patent reform